Literature DB >> 3690402

Carnitine and carnitine esters in rat bile and human duodenal fluid.

J J Hamilton1, P Hahn.   

Abstract

The recent discovery of carnitine and its esters in rat bile has led to much speculation about its role. The objectives of these studies were to investigate the origin of carnitine esters in rat bile and to study the presence of carnitine in human bile-rich duodenal fluid. Bile was collected from chow-fed (n = 11), fasted (72 h, n = 6), and fasted plus 2-tetradecylglycidic acid administered (72 h, n = 5) male adult rats under sodium pentobarbital anaesthesia. Carnitine and carnitine ester content was measured in the bile and compared with serum and liver carnitine. Bile from fed rats was found to contain 80% acylcarnitine, one-third of this as long chain carnitine esters. Fasting caused no change in the secretion rate of acylcarnitine into the bile, although long chain carnitine ester secretion almost doubled. Conversely, 2-tetradecylglycidic acid treatment caused a decrease in long chain carnitine ester secretion into bile. Duodenal fluid was collected from patients with suspected cholelithiasis (n = 10) before and after pancreozymin-cholecystokinin injection. Although carnitine concentration was variable, it was consistently 80% esterified. These data associate bile carnitine with hepatic carnitine metabolism and establish the presence of carnitine and carnitine esters in the human intestinal lumen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3690402     DOI: 10.1139/y87-283

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Relationship between drug absorption enhancing activity and membrane perturbing effects of acylcarnitines.

Authors:  E L LeCluyse; L E Appel; S C Sutton
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

2.  L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.

Authors:  Lorenzo Di Liberato; Arduino Arduini; Claudia Rossi; Augusto Di Castelnuovo; Cosima Posari; Paolo Sacchetta; Andrea Urbani; Mario Bonomini
Journal:  J Nephrol       Date:  2014-03-06       Impact factor: 3.902

3.  Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles.

Authors:  G B Park; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

4.  Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines.

Authors:  Sarah A Smith; Sayaka A Ogawa; Lillian Chau; Kelly A Whelan; Kathryn E Hamilton; Jie Chen; Lu Tan; Eric Z Chen; Sue Keilbaugh; Franz Fogt; Meenakshi Bewtra; Jonathan Braun; Ramnik J Xavier; Clary B Clish; Barry Slaff; Aalim M Weljie; Frederic D Bushman; James D Lewis; Hongzhe Li; Stephen R Master; Michael J Bennett; Hiroshi Nakagawa; Gary D Wu
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.